Immunosuppressive drugs: the first 50 years and a glance forward.
about
Expanding Regulatory T Cells Alleviates Chikungunya Virus-Induced Pathology in MiceReview article: the management of autoimmune hepatitis beyond consensus guidelinesProlonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferretsSynthesis, Structural Analysis, and Biological Evaluation of Thioxoquinazoline Derivatives as Phosphodiesterase 7 InhibitorsPro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsDiagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsInherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosisCyclosporin A: a new drug in the field of canine dermatologyPDE 7 inhibitors: new potential drugs for the therapy of spinal cord injuryMycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology.On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosisMycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.Therapeutic options for immune-mediated thrombocytopenia.A novel immunomodulatory treatment involving mycophenolate mofetil and corticosteroids for pediatric autoimmune cytopenias.A patient with Pfeifer-Weber-Christian disease--successful therapy with cyclosporin A: case report.Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose.Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-κB, AP-1 and NF-ATEverolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.Treg cell resistance to apoptosis in DNA vaccination for experimental autoimmune encephalomyelitis treatmentSpontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect.IL-6 induced by Staphylococcus aureus infection prevents the induction of skin allograft acceptance in mice.Purine synthesis and increased Agrobacterium tumefaciens transformation of yeast and plants.Streptomyces-derived quorum-sensing systems engineered for adjustable transgene expression in mammalian cells and mice.Septic arthritis in the era of immunosuppressive treatments.Review of the immunosuppressant enteric-coated mycophenolate sodium.Mechanisms of action of mycophenolate mofetil.The relative effects of different systemic immunosuppressives on skin cancer development in organ transplant patients.Autoimmune hepatitis: focusing on treatments other than steroids.Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunizationCharacterization of Discrete Phosphopantetheinyl Transferases in Streptomyces tsukubaensis L19 Unveils a Complicate Phosphopantetheinylation NetworkOral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.Immunosuppression with cyclophosphamide favors reinfection with recombinant Toxoplasma gondii strains.Vaccine-preventable infections in Systemic Lupus Erythematosus.Vaccination in patients with chronic rheumatic or autoimmune diseases.Transition states of Plasmodium falciparum and human orotate phosphoribosyltransferases.Transition state analogues of Plasmodium falciparum and human orotate phosphoribosyltransferases.FK506 attenuates thymic output in patients with myasthenia gravis.Hepatic inflammation and progressive liver fibrosis in chronic liver disease.Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8)Autoantibody-negative autoimmune hepatitis.
P2860
Q24701758-01AC2216-A285-41B3-9CF8-1A1197EDAF94Q26864272-3CBF9F9C-52D7-4921-8FC7-7EE911DF236BQ27334946-96C14F95-AB18-4E0C-9193-F2E2575B0D17Q27654567-704DF6B3-96EB-41EE-9158-0ACE74FF34A6Q28076161-B703A697-F4F5-4E63-BCE2-33A272460F00Q28076505-9B3FD0D5-88E7-4A85-86E5-153F3961C9A4Q28201501-1EEC1AFD-6BB3-4854-A891-CDA4D0441D6AQ28251267-913205DA-9DC2-4AA0-B49B-5F1314079D44Q28477025-8FB3C396-EE89-4FAA-9731-7ECD305B57DDQ31116844-E751EF07-42EF-434F-A9AE-102BA59EAB40Q33346257-0510A814-EE10-49E6-B366-598D420C2264Q33393187-77A4AC2D-DEA0-4504-A409-03F8F841E920Q33399601-CA44EB35-86A5-4DB7-AAA6-2B585A42F571Q33435295-4D0968DC-A453-440A-9CE6-36B0DE53C4C8Q33526876-0A173032-99E3-4162-A5CB-6874D81B9A4DQ34026264-6D0B0E0C-0C46-4BD0-BB41-2DAF05C54528Q34170778-B638638C-4D82-49E9-8495-53FBC1DAEA3BQ34449084-648E0B24-CD80-4240-B5EA-58E4942EFFCBQ34482931-8F2C2466-E612-4F6C-960D-282B3A157759Q34546455-0556ADCA-B5A3-4BD4-B35F-6BE882CB4B89Q34873028-3AF78956-CA3B-41FC-9D58-9353095C70A6Q35143799-269CC8F2-D253-410B-81D5-C770B254410EQ35186186-2075D7D4-E208-4A7C-A7D6-9B31F26AA602Q35760368-D8704A24-3B28-4B76-B31A-7FF7092E39F1Q35784063-E31A7D30-429C-4488-B3CA-54D33770F8ACQ36085841-24AEE293-0AE9-4499-B8B2-6B7A3148F18AQ36103139-B3CA547F-1F6B-410A-A683-D2A1952F27C8Q36231841-0EC25715-1D84-4BD6-BC36-F49978C1DB63Q36649589-E690E559-4C31-4FF9-88D7-92EC78CBC37BQ36773941-12C12268-7CE5-45BE-9A3F-B2484213C6C3Q36821577-E011F373-0BF6-41E7-88CB-DFE4004FB117Q36899227-F0D56141-789C-4E18-A4CF-A101B45A817DQ37135056-1BF00CF3-DE96-44EC-B74D-8AE669F5906FQ37141193-68FEBB63-37AB-457A-AFD4-1EC7262C783CQ37159817-5F09A35B-8241-43BE-9151-A046760D0B0EQ37348966-39A44FE2-E032-44A7-B675-9C1E86B223E9Q37517952-2F00A6A9-7BAB-403E-B228-49CDE13DBAD2Q37629675-6840D9C5-FE44-4977-A4F9-A220B7B72CB7Q37729461-FE744438-6DDB-4D66-94C7-94865D4FE520Q37970311-7C04D4E0-9795-427E-B21E-C9ED836FAD18
P2860
Immunosuppressive drugs: the first 50 years and a glance forward.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunosuppressive drugs: the first 50 years and a glance forward.
@ast
Immunosuppressive drugs: the first 50 years and a glance forward.
@en
type
label
Immunosuppressive drugs: the first 50 years and a glance forward.
@ast
Immunosuppressive drugs: the first 50 years and a glance forward.
@en
prefLabel
Immunosuppressive drugs: the first 50 years and a glance forward.
@ast
Immunosuppressive drugs: the first 50 years and a glance forward.
@en
P1433
P1476
Immunosuppressive drugs: the first 50 years and a glance forward.
@en
P2093
A C Allison
P356
10.1016/S0162-3109(00)00186-7
P577
2000-05-01T00:00:00Z